Rabbit Recombinant Monoclonal CYP27B1 antibody. Suitable for IP, WB, IHC-P and reacts with Human, Mouse, Rat, Recombinant fragment samples. Cited in 21 publications.
View Alternative Names
CYP1ALPHA, CYP27B, CYP27B1, 25-OHD-1 alpha-hydroxylase, 25-hydroxyvitamin D(3) 1-alpha-hydroxylase, Calcidiol 1-monooxygenase, Cytochrome P450 subfamily XXVIIB polypeptide 1, Cytochrome P450C1 alpha, Cytochrome P450VD1-alpha, Cytochrome p450 27B1, VD3 1A hydroxylase
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CYP27B1 antibody [EPR20271] (AB206655)
Immunohistochemical analysis of paraffin-embedded human kidney tissue labeling CYP27B1 with ab206655 at 1/2000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Strong cytoplasmic staining on distal convoluted tubules of human kidney. Weaker cytoplasmic staining on proximal convoluted tubules [PMID : 23416105] [PMID : 12050281].
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IP
Supplier Data
Immunoprecipitation - Anti-CYP27B1 antibody [EPR20271] (AB206655)
CYP27B1 was immunoprecipitated from 0.35 mg of MeWo (Human malignant melanoma cell line) whole cell lysate with ab206655 at 1/40 dilution. Western blot was performed from the immunoprecipitate using ab206655 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : MeWo whole cell lysate, 10 μg (Input).
Lane 2 : ab206655 IP in MeWo whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab206655 in MeWo whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds.
All lanes:
Immunoprecipitation - Anti-CYP27B1 antibody [EPR20271] (ab206655)
Predicted band size: 57 kDa
Observed band size: 45 kDa
false
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CYP27B1 antibody [EPR20271] (AB206655)
Immunohistochemical analysis of paraffin-embedded rat kidney tissue labeling CYP27B1 with ab206655 at 1/2000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Cytoplasmic staining on rat kidney tubules [PMID : 23416105] [PMID : 12050281].
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CYP27B1 antibody [EPR20271] (AB206655)
Immunohistochemical analysis of paraffin-embedded mouse kidney tissue labeling CYP27B1 with ab206655 at 1/2000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Cytoplasmic staining on mouse kidney tubules [PMID : 23416105] [PMID : 12050281].
Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- WB
Supplier Data
Western blot - Anti-CYP27B1 antibody [EPR20271] (AB206655)
Blocking/Dilution buffer : 5% NFDM/TBST.
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 16061850).
All lanes:
Western blot - Anti-CYP27B1 antibody [EPR20271] (ab206655) at 1/1000 dilution
Lane 1:
Human fetal kidney lysate at 20 µg
Lane 2:
Human fetal liver lysate at 20 µg
Secondary
All lanes:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/4000 dilution
Predicted band size: 57 kDa
Observed band size: 45 kDa
false
Exposure time: 30s
- WB
Supplier Data
Western blot - Anti-CYP27B1 antibody [EPR20271] (AB206655)
Blocking/Dilution buffer : 5% NFDM/TBST.
THP-1 is a negative control (PMID : 16930540).
The molecular weight observed is consistent with what has been described in the literature (PMID : 16061850).
All lanes:
Western blot - Anti-CYP27B1 antibody [EPR20271] (ab206655) at 1/2000 dilution
Lane 1:
THP-1 (Human monocytic leukemia cell line) whole cell lysate at 20 µg
Lane 2:
HaCaT (Human keratinocyte cell line) whole cell lysate at 20 µg
Lane 3:
MeWo (Human malignant melanoma cell line) whole cell lysate at 20 µg
Lane 4:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 5:
Human fetal heart lysate at 20 µg
Lane 6:
Human fetal brain lysate at 20 µg
Secondary
Lanes 1 - 4:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Lanes 5 - 6:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/4000 dilution
Predicted band size: 57 kDa
Observed band size: 45 kDa,70 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-CYP27B1 antibody [EPR20271] (AB206655)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure times : Lane 1, 2, 3 and 4 : 1 second; Lane 5 : 3 seconds.
All lanes:
Western blot - Anti-CYP27B1 antibody [EPR20271] (ab206655) at 1/1000 dilution
Lane 1:
Mouse heart lysate at 10 µg
Lane 2:
Mouse kidney lysate at 10 µg
Lane 3:
Rat heart lysate at 10 µg
Lane 4:
Rat kidney lysate at 10 µg
Lane 5:
Rat brain lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 57 kDa
Observed band size: 57 kDa
false
- WB
Supplier Data
Western blot - Anti-CYP27B1 antibody [EPR20271] (AB206655)
Blocking buffer and concentration : 5% NFDM/TBST. Diluting buffer and concentration : 5% NFDM/TBST.
Lane 1:
Western blot - Anti-CYP27B1 antibody [EPR20271] (ab206655) at 1/1000 dilution
Lane 2:
Anti-His-tag antibody at 1/200 dilution
All lanes:
Recombinant CYP27B1 protein
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 57 kDa
Observed band size: 56 kDa
false
Exposure time: 3s
Related conjugates and formulations (1)
-
Anti-CYP27B1 antibody [EPR20271] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The active form of vitamin D produced by CYP27B1 is essential for maintaining mineral homeostasis and bone health. The enzyme is not traditionally part of a larger protein complex but works closely with vitamin D binding proteins to interact with its substrates. The active vitamin D influences calcium and phosphate balance in the body which has implications for overall bone integrity and immune system regulation.
Pathways
CYP27B1 plays a significant role in the vitamin D metabolic pathway and the calcium signaling pathway. It functions upstream of the vitamin D receptor (VDR) that helps control calcium absorption in the gut. CYP24A1 another related cytochrome P450 enzyme participates in degrading the active form of vitamin D maintaining an important balance within the system. Together these pathways and proteins help regulate calcium levels critical to many physiological processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (21)
Recent publications for all applications. Explore the full list and refine your search
World journal of diabetes 16:102727 PubMed40548274
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biochemistry and biophysics reports 41:101925 PubMed40134939
2025
Applications
Unspecified application
Species
Unspecified reactive species
mBio 15:e0213724 PubMed39475231
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 16: PubMed38730587
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:3778 PubMed38355711
2024
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 10:e24499 PubMed38298727
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in veterinary science 10:1265203 PubMed37808100
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of biological sciences 19:610-624 PubMed36632467
2023
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 8:e10184 PubMed36033312
2022
Applications
Unspecified application
Species
Unspecified reactive species
Annals of translational medicine 10:506 PubMed35928745
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com